In the title salt, (C 17 H 17 F 6 N 2 O) 2 [Sn(C 6 H 5 ) 2 Cl 4 ], the complete anion is generated by crystallograaphic inversion symmetry, giving a trans-SnC 2 Cl 4 octahedral coordination geometry for the metal atom. In the cation, the quinoline residue is almost normal to the other atoms, so that the ion has an L-shaped conformation [the C-C-C-C torsion angle linking the fused-ring systems is 100.9 (7) ]; the six-membered piperidin-1-ium ring has a chair conformation. An intramolecular N-HÁ Á ÁO interaction occurs. In the crystal, N-HÁ Á ÁCl and O-HÁ Á ÁCl hydrogen bonds link the components into a supramolecular chain propagating along the a axis. C-HÁ Á ÁCl interactions are also present.
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Experimental
Crystal data (C 17 H 17 Hydrogen-bond geometry (Å , ). 
Data collection: COLLECT (Hooft, 1998 ); cell refinement: DENZO (Otwinowski & Minor, 1997) and COLLECT; data reduction: DENZO and COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010 Mefloquine, manufactured as the racemic erythro hydrochloride salt, is a synthetic analogue of quinine used in the prevention and treatment for malaria in combination with other drugs (Maguire et al., 2006) . While both enantiomers of erythro mefloquinium hydrochloride are active, the (+) form is the more potent against the D6 and W2 strains of Plasmodium falciparum (Karle & Karle, 2002) . Mefloquine was an effective antimalarial agent, when first introduced in 1971, and because of its long half-life was a good prophylactic. However by the end of the 20th century, a widespread resistance of Plasmodium sp. developed and this, together with undesirable side-effects such as birth defects, anxiety, aggression, seizures, nightmares, neuropathy, insomnia, central nervous system problems, acute depression, and urinary disorders, have resulted in a decline in its use (Croft & Herxheimer, 2002; Dow et al., 2004) . Much effort is underway to find mefloquine analogues having increased efficacity and reduced adverse side-effects (Lima et al. 2002; Biot et al., 2000; Roesner et al., 1981) . Mefloquine derivatives are also undergoing tests against other diseases, for example as anti-viral and anti-tuberculosis agents (Kunin & Ellis, 2007) . A few crystal structures of mefloquine (Skórska et al., 2005) and mefloquinium salts, including hydrated chloride (Karle & Karle, 1991a; Karle & Karle, 2002; Skórska et al., 2005) , methylsulfonate (Karle & Karle, 1991b) , tetrachlorocobaltate (Skórska et al., 2005) , and tetrachlorocuprate and tetrabromocadmate salts (Obaleye et al., 2009 ) have been reported. We now report the structure of the title salt, (I).
The asymmetric unit of (I) comprises a piperidin-1-ium cation, Fig. 1 , and half a tetrachloridodiphenylstannate anion, The Cl2 atom only forms one signficant hydrogen bond, i.e. with the hydroxyl group. The hydrogen bonding interactions generate a supramolecular chain orientated along the a axis. The crystal packing comprises layers supramolecular chains in the ab plane with the major interactions between them being of the type C-H···Cl, Table 1 and Fig. 4 . Globally, the crystal structure comprises alternating layers of cations and anions. : 3323, 3193, 2989, 2959, 2844, 1601, 1575, 1519, 1479, 1455, 1432, 1374, 1317, 1268, 1214, 1183, 1142, 1111, 1049, 998, 917, 837, 779, 740, 713, 697, 669, 532, 458, 434 cm -1 .
Refinement
The H atoms were geometrically placed (O-H = 0.84 Å, N-H = 0.92 Å, and C-H = 0.95-1.00 Å) and refined as riding with U iso (H) = 1.2U eq (N, C) and 1.5U eq (O). Figures   Fig. 1 . The molecular structure of the cation in (I) showing displacement ellipsoids at the 35% probability level. Fig. 2 . The molecular structure of the anion in (I) showing displacement ellipsoids at the 35% probability level. The unlabelled non-hydrogen atoms are generated by the symmetry operation (1-x, 1-y, 2-z). 
